COVID-19 pandemic: challenges ahead
Abstract Since December 2019, health systems worldwide have faced the pandemic caused by the new severe acute respiratory syndrome coronavirus 2. The pandemic began in China and has spread throughout the world. This new coronavirus has a high transmission capacity and elevated lethality in people over 60 years old and in those with risk factors (obesity, diabetes, and systemic arterial hypertension); those characteristics have a different proportion in each country. At present, there is no specific, effective, and safe treatment to treat this virus. In this review, an analysis is made on the differences in epidemiological aspects of the disease and its presentation in pediatric patients; the poorly-based recommendation for using an empirical combination of antimalarials plus antimicrobials as antiviral treatment; the indication of intravenous steroids; and the possible influence of antihypertensive drugs on the course of the disease.
Main Authors: | , , , , , |
---|---|
Format: | Digital revista |
Language: | English |
Published: |
Instituto Nacional de Salud, Hospital Infantil de México Federico Gómez
2020
|
Online Access: | http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S1665-11462020000500242 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
id |
oai:scielo:S1665-11462020000500242 |
---|---|
record_format |
ojs |
spelling |
oai:scielo:S1665-114620200005002422020-11-10COVID-19 pandemic: challenges aheadMárquez-González,HoracioMiranda-Novales,María G.Solórzano-Santos,FortinoKlunder-Klunder,MiguelGarduño-Espinoza,JuanMéndez-Galván,Jorge F. Coronavirus 2019 disease Severe acute respiratory syndrome coronavirus 2 Hydroxychloroquine Azithromycin Steroids Angiotensin-converting enzyme-2 Abstract Since December 2019, health systems worldwide have faced the pandemic caused by the new severe acute respiratory syndrome coronavirus 2. The pandemic began in China and has spread throughout the world. This new coronavirus has a high transmission capacity and elevated lethality in people over 60 years old and in those with risk factors (obesity, diabetes, and systemic arterial hypertension); those characteristics have a different proportion in each country. At present, there is no specific, effective, and safe treatment to treat this virus. In this review, an analysis is made on the differences in epidemiological aspects of the disease and its presentation in pediatric patients; the poorly-based recommendation for using an empirical combination of antimalarials plus antimicrobials as antiviral treatment; the indication of intravenous steroids; and the possible influence of antihypertensive drugs on the course of the disease.info:eu-repo/semantics/openAccessInstituto Nacional de Salud, Hospital Infantil de México Federico GómezBoletín médico del Hospital Infantil de México v.77 n.5 20202020-10-01info:eu-repo/semantics/articletext/htmlhttp://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S1665-11462020000500242en10.24875/bmhim.20000166 |
institution |
SCIELO |
collection |
OJS |
country |
México |
countrycode |
MX |
component |
Revista |
access |
En linea |
databasecode |
rev-scielo-mx |
tag |
revista |
region |
America del Norte |
libraryname |
SciELO |
language |
English |
format |
Digital |
author |
Márquez-González,Horacio Miranda-Novales,María G. Solórzano-Santos,Fortino Klunder-Klunder,Miguel Garduño-Espinoza,Juan Méndez-Galván,Jorge F. |
spellingShingle |
Márquez-González,Horacio Miranda-Novales,María G. Solórzano-Santos,Fortino Klunder-Klunder,Miguel Garduño-Espinoza,Juan Méndez-Galván,Jorge F. COVID-19 pandemic: challenges ahead |
author_facet |
Márquez-González,Horacio Miranda-Novales,María G. Solórzano-Santos,Fortino Klunder-Klunder,Miguel Garduño-Espinoza,Juan Méndez-Galván,Jorge F. |
author_sort |
Márquez-González,Horacio |
title |
COVID-19 pandemic: challenges ahead |
title_short |
COVID-19 pandemic: challenges ahead |
title_full |
COVID-19 pandemic: challenges ahead |
title_fullStr |
COVID-19 pandemic: challenges ahead |
title_full_unstemmed |
COVID-19 pandemic: challenges ahead |
title_sort |
covid-19 pandemic: challenges ahead |
description |
Abstract Since December 2019, health systems worldwide have faced the pandemic caused by the new severe acute respiratory syndrome coronavirus 2. The pandemic began in China and has spread throughout the world. This new coronavirus has a high transmission capacity and elevated lethality in people over 60 years old and in those with risk factors (obesity, diabetes, and systemic arterial hypertension); those characteristics have a different proportion in each country. At present, there is no specific, effective, and safe treatment to treat this virus. In this review, an analysis is made on the differences in epidemiological aspects of the disease and its presentation in pediatric patients; the poorly-based recommendation for using an empirical combination of antimalarials plus antimicrobials as antiviral treatment; the indication of intravenous steroids; and the possible influence of antihypertensive drugs on the course of the disease. |
publisher |
Instituto Nacional de Salud, Hospital Infantil de México Federico Gómez |
publishDate |
2020 |
url |
http://www.scielo.org.mx/scielo.php?script=sci_arttext&pid=S1665-11462020000500242 |
work_keys_str_mv |
AT marquezgonzalezhoracio covid19pandemicchallengesahead AT mirandanovalesmariag covid19pandemicchallengesahead AT solorzanosantosfortino covid19pandemicchallengesahead AT klunderklundermiguel covid19pandemicchallengesahead AT gardunoespinozajuan covid19pandemicchallengesahead AT mendezgalvanjorgef covid19pandemicchallengesahead |
_version_ |
1756227134492246016 |